Ribbon Bio was named Rising Star of the Year 2025 and recognized in the BioTech & Health category at the EY Scale-up Award in Austria.
The recognition marks a milestone in a year of significant advancements for the company, following the launch of MiroSynth™ DNA — highly accurate, long, and complex synthetic DNA molecules that are pushing the boundaries of scientific possibilities. With MiroSynth™, we’re aiming to accelerate breakthrough research in molecular biology, gene therapy, vaccine development, and countless other synthetic biology applications.
This achievement reflects the company’s focus on scientific innovation, product development, and long-term impact in the field of biotechnology.
